piperidic acid
Small moleculeexperimental
GABA is the chief inhibitory neurotransmitter in the developmentally mature mammalian central nervous system. Its principal role is reducing neuronal excitability throughout the nervous system. — Wikipedia
Clinical trial activity
4 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2012 (NCT01561508)
Timeline
Indications
Mechanism of action
- DNA gyraseINHIBITOR
DNA gyrase inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
NCCCC(=O)O- Mol. weight
- 103.12 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaGABA ↗
- ChEMBLCHEMBL96 ↗
- WikipediaΓ-Aminobutyric acid ↗
- WikipediaGamma-Aminobutyric acid ↗
Also known as
- 4abu
- 4abu
- 4-aminobutanoic acid
- 4-aminobutanoic acid
- 4-aminobutanoic acid
- 4-aminobutyric acid
- 4-aminobutyric acid
- 4-aminobutyric acid
- aminalon
- aminobutyric acid
- aminobutyric acid
- aminobutyric acid
- gaba
- gaba
- gaba
- gaba
- gaba
- gaba
- gaballon
- .gamma.-aminobutyric acid
- gamma aminobutyric acid
- gamma aminobutyric acid
- gamma-aminobutyric acid
- gamma-aminobutyric acid
- gamma-aminobutyric acid
- gamma-aminobutyric acid
- gamma-aminobutyric acid
- piperidic acid
- piperidic acid
- piperidic acid
- piperidinic acid
- piperidinic acid
- γ-aminobutanoic acid
- γ-aminobutanoic acid
- γ-aminobuttersäure
- γ-aminobuttersäure
- γ-aminobutyric acid
- γ-aminobutyric acid
- γ-amino-n-butyric acid
- γ-amino-n-butyric acid
- ω-aminobutyric acid
- ω-aminobutyric acid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02928328 | N/A | Oct 1, 2016 | Aalborg University |
| NCT02002130 | Phase 1 | Jan 1, 2015 | Diamyd, Janssen Pharmaceutica NV, Juvenile Diabetes Research Foundation, NOW Foods, University of Alabama, Birmingham |
| NCT01781884 | N/A | Jan 1, 2013 | Fudan University, University of Toronto |
| NCT01561508 | Phase 2 | Jun 1, 2012 | University of Alabama, Birmingham |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Alabama, Birmingham | Academic/Hospital | 2 | 2 | 2 | 2012 |
| Aalborg University | Academic/Hospital | 1 | 1 | 1 | 2016 |
| Diamyd | For profit | 1 | 0 | 1 | 2015 |
| Fudan University | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Janssen Pharmaceutica NV | For profit | 1 | 0 | 1 | 2015 |
| Juvenile Diabetes Research Foundation | Academic/Hospital | 1 | 0 | 1 | 2015 |
| NOW Foods | For profit | 1 | 0 | 1 | 2015 |
| University of Toronto | Academic/Hospital | 1 | 0 | 1 | 2013 |
8 organizations
Page 1 / 1